Sign in

CIK 0001404644 · Non-accelerated filer<br>Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
980542593
Phone
(877) 237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
  1. DEF 14A Proxy Proxy Statement
  2. 8-K Event Executive or director change
  3. 8-K Event Regulation FD disclosure
  4. 8-K Event Executive or director change
  5. 8-K Event Results of operations
  6. 10-K Report Annual Report
  7. 8-K Event Regulation FD disclosure
  8. 8-K Event Executive or director change
  9. 8-K Event Regulation FD disclosure
  10. 8-K Event Material agreement · Acquisition or sale completed · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shareholder vote results · Director nominations · Regulation FD disclosure
  11. 8-K Event Other events
  12. 8-K Event Other events
  13. 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Other events
  14. 8-K Event Material agreement · Unregistered share sale · Change in control · Executive or director change · Regulation FD disclosure
  15. 8-K Event Shareholder vote results
  16. DEF 14A Proxy Proxy Statement
  17. 8-K Event Executive or director change
  18. 10-K Report Annual Report
  19. 8-K Event Exit or restructuring costs · Executive or director change
  20. 8-K Event Regulation FD disclosure

Page 3 of 9 · 178 filings